Le Lézard
Classified in: Health, Science and technology
Subject: CCA

Lilly Confirms Date and Conference Call for Fourth-Quarter 2019 Financial Results Announcement


INDIANAPOLIS, Jan. 16, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter and full-year 2019 financial results on Thursday, January 30, 2020. Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial performance.

The conference call will begin at 9 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/webcasts-and-presentations. A replay will also be available on the website following the conference call.

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com.  F-LLY   

Refer to:
Mark Taylor; [email protected]; (317) 276-5795 (Media)   
Kevin Hern; [email protected]; (317) 277-1838 (Investors)        

Eli Lilly and Company logo. (PRNewsfoto/Eli Lilly and Company)

 

SOURCE Eli Lilly and Company


These press releases may also interest you

at 05:35
Atom Bioscience Enrolling Patients in US as Part of a Global Phase 2b/3 Clinical Trial of a New Investigational Treatment for Chronic Gout
Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new treatments for inflammatory and metabolic diseases, has begun enrolling patients in the US for in a Phase 2b/3 clinical...

at 05:30
Enormous Demand for Weight-Loss Drugs Drives Up Total U.S. Prescription Spending
Blockbuster growth in weight-loss drugs was the main driver of a 13.5% increase in spending on prescription medications in the U.S. in 2023, according to ASHP's (American Society of Health-System Pharmacists) report, National Trends in Prescription...

at 05:26
Paley Institute's Global Expansion: Dr. Dror Paley Introduces Instituto Paley LatinoAmerica with Dr. León Mora and CORA Group in Colombia
Renowned orthopedic surgeon Dr. Dror Paley, in partnership with Dr. León Mora and the Cora Group Excellence Center for Orthopedic Reconstructive and Limb Lengthening Surgery, is...

at 05:15
ITRI Sweeps 2024 Edison Awards with Four Groundbreaking Innovations
The Industrial Technology Research Institute (ITRI) triumphed at the recent Edison Awardstm in Fort Myers, Florida, securing recognition for four exceptional technological breakthroughs: the Novel Dual-Targeted Therapy for Glaucoma, Key Functional...

at 05:00
Beta-Glucan Market worth $800 million by 2029 - Exclusive Report by MarketsandMarketstm
The Beta-Glucan Market is estimated at USD 542 million in 2024 and is projected to reach USD 800 million by 2029, at a CAGR of 8.1% from 2024 to 2029 according to a report published by MarketsandMarketstm. The growth of the beta-glucan market is...

at 05:00
Geek+ and System Teknik deploy first PopPick solution in the Nordics for the pharmacy group Med24.dk
Geekplus, the global leader in mobile robot and smart logistics solutions, has deployed the first Shelf-to-Person PopPick project in the Nordics for one of the biggest online pharmacy wholesalers in the region, Med24.dk. System Teknik partnered on...

More news about Health...


News published on and distributed by: